The responses of the ER+ tumor cells themselves extend these observations beyond application to other solid tumors, and underscore the consequences of exposure to estrogen in untreated ER+ breast cancers, and responses to therapeutic anti-estrogens. The gene discussed is ESR1; the disease is breast cancer.